These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1386833)

  • 1. Specific down-regulation of allograft reactivity at the cellular level: graft cells and responder T cells.
    Müller-Ruchholtz W
    Immunol Lett; 1992 Mar; 32(1):1-6. PubMed ID: 1386833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-induced delivery of the costimulatory signal for a v-mos-transfected nonallostimulating, MHC I+II+ clone of the murine macrophage cell line P388D1 and induction of tolerance.
    Müller-Ruchholtz W; Seliger B; Eckstein V; Wottge HU
    Transplant Proc; 1991 Feb; 23(1 Pt 1):226-8. PubMed ID: 1824978
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC allograft immunogenicity--its role in bone marrow transplantation and its constant downregulation.
    Müller-Ruchholtz W
    Immunol Invest; 1991 Apr; 20(2):199-206. PubMed ID: 1864639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.
    Marijt WA; Veenhof WF; Brand A; Goulmy E; Fibbe WE; Willemze R; van Rood JJ; Falkenburg JH
    J Exp Med; 1991 Jan; 173(1):101-9. PubMed ID: 1985117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
    Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.
    Voogt PJ; Fibbe WE; Marijt WA; Goulmy E; Veenhof WF; Hamilton M; Brand A; Zwann FE; Willemze R; van Rood JJ
    Lancet; 1990 Jan; 335(8682):131-4. PubMed ID: 1967432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microchimerism, dendritic cell progenitors and transplantation tolerance.
    Thomson AW; Lu L; Murase N; Demetris AJ; Rao AS; Starzl TE
    Stem Cells; 1995 Nov; 13(6):622-39. PubMed ID: 8590864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.
    Mathew JM; Marsh JW; Susskind B; Mohanakumar T
    J Clin Invest; 1993 Mar; 91(3):900-6. PubMed ID: 8450068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antagonist mutant IL-15/Fc promotes transplant tolerance.
    Zheng XX; Gao W; Donskoy E; Neuberg M; Ruediger M; Strom TB; Moll T
    Transplantation; 2006 Jan; 81(1):109-16. PubMed ID: 16421485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft.
    Herzog WR; Zanker B; Irschick E; Huber C; Franz HE; Wagner H; Kabelitz D
    Transplantation; 1987 Mar; 43(3):384-9. PubMed ID: 3547795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split tolerance induced by orthotopic liver transplantation in mice.
    Dahmen U; Qian S; Rao AS; Demetris AJ; Fu F; Sun H; Gao L; Fung JJ; Starzl TE
    Transplantation; 1994 Jul; 58(1):1-8. PubMed ID: 8036695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.